| MA Lead-Asthma Biological | AstraZeneca | China | 2026-06-25 |
| Global Study Manager - Haematology | AstraZeneca | Amsterdam, The Netherlands | 2026-06-25 |
| P&R Lead and NPP | AstraZeneca | Seoul, South Korea | 2026-06-25 |
| (Sr.) Country Study Manager - Cell Therapy | AstraZeneca | Beijing, China | 2026-06-25 |
| Account Specialist/Manager โ Rare Diseases โ HN | AstraZeneca | Hanoi, Vietnam | 2026-06-25 |
| Travel & Expenses Associate Analyst (Mandarin Speaker) | AstraZeneca | Malaysia | 2026-06-25 |
| CMC Portfolio Lead | AstraZeneca | Shanghai, China | 2026-06-25 |
| Global Study Lead | AstraZeneca | United Kingdom | 2026-06-25 |
| Diagnostics Lead | AstraZeneca | Mexico City, Mexico | 2026-06-25 |
| MA Lead-Asthma | AstraZeneca | China | 2026-06-25 |
| Field Scientific Leader (Cardiovascular & Renal) - ฤฐstanbul | AstraZeneca | Istanbul, Turkey | 2026-06-25 |
| Market Access Manager SK | AstraZeneca | Bratislava, Slovakia | 2026-06-25 |
| RA (Senior) Specialist/Associate Manager | AstraZeneca | Seoul, South Korea | 2026-06-25 |
| HTA & Modelling Science Lead | AstraZeneca | Barcelona, Spain | 2026-06-25 |
| CEE-BA Leadership Trainee Program (Romania) | AstraZeneca | Bucharest, Romania | 2026-06-25 |
| Senior Specialist, Biometrics Business Management and Operations | AstraZeneca | United Kingdom | 2026-06-25 |
| CEE-BA Leadership Trainee HU | AstraZeneca | Budapest, Hungary | 2026-06-25 |
| Senior Manager - SHE | AstraZeneca | China | 2026-06-25 |
| Early Asset Management Lead (m/w/d) Oncology | AstraZeneca | Hamburg, Germany | 2026-06-25 |
| Cell Therapy Lab Operations Manager | AstraZeneca | Shanghai, China | 2026-06-25 |
| Pathway Optimization Manager (m/w/d) Oncology | AstraZeneca | Hamburg, Germany | 2026-06-25 |
| Study Start-up Manager (m/w/d) Cell Therapy | AstraZeneca | United Kingdom | 2026-06-25 |
| Local Feasibility Lead (m/w/d) - Cell Therapy | AstraZeneca | Azerbaijan | 2026-06-25 |
| Dx Advisor-ATTR | AstraZeneca | China | 2026-06-25 |
| Global Study Associate Manager | AstraZeneca | United Kingdom | 2026-06-25 |
| Study Contracts Manager - Cell Therapy | AstraZeneca | Australia | 2026-06-25 |
| Manager - Security | AstraZeneca | China | 2026-06-25 |
| Site Engagement and Alliance Manager | AstraZeneca | Shanghai, China | 2026-06-25 |
| ใAlexion JapanใKey Customer Lead,IgAN ๏ผTokyo๏ผ | AstraZeneca | Tokyo, Japan | 2026-06-25 |
| ใAlexion JapanใKey Customer Lead,IgAN ๏ผOsaka๏ผ | AstraZeneca | Tokyo, Japan | 2026-06-25 |
| Market Access Specialist | AstraZeneca | Taiwan | 2026-06-25 |
| Site Operations Lead | AstraZeneca | Beijing, China | 2026-06-25 |
| (Associate) Country Study Manager - CVRM | AstraZeneca | United Kingdom | 2026-06-25 |
| Global Study Associate Manager | AstraZeneca | United Kingdom | 2026-06-25 |
| Therapy Area Specialist (m/w/d) Heart Failure โ Region: Heilbronn, Gรถppingen, Aalen/Heidenheim, Schwรคbisch Hall | AstraZeneca | United Kingdom | 2026-06-25 |
| Product Specialist - Oncology | AstraZeneca | Singapore, Singapore | 2026-06-25 |
| Global Study Associate Manager | AstraZeneca | United Kingdom | 2026-06-25 |
| Global Study Associate Manager | AstraZeneca | United Kingdom | 2026-06-25 |
| Manager I, Business Management & Operations | AstraZeneca | Shanghai, China | 2026-06-25 |
| Oncology Business Manager (Gyn/GU) - Minneapolis | AstraZeneca | United Kingdom | 2026-06-25 |
| Oncology Business Manager (Gyn/GU) - Northwest | AstraZeneca | United Kingdom | 2026-06-25 |
| Oncology Account Specialist (Gyn/GU) โ Sacramento, CA | AstraZeneca | United Kingdom | 2026-06-25 |
| Therapy Area Specialist Oncology (Breast Cancer/Gynae) - Vilnius | AstraZeneca | Vilnius, Lithuania | 2026-06-25 |
| Sr Alliance Manager, China External Innovation | Novo Nordisk | Shanghai, China | 2026-06-25 |
| Associate Global Pricing Lead | Novo Nordisk | Bengaluru, India | 2026-06-25 |
| Advanced Business Analyst I-OMP | Novo Nordisk | Bengaluru, India | 2026-06-25 |
| CMC Associate Manager | Novo Nordisk | Beijing, China | 2026-06-25 |
| Senior Gross To Net Forecasting & Innovation Manager | Novo Nordisk | United States | 2026-06-25 |
| Security Analyst III | Novo Nordisk | United States | 2026-06-25 |
| Manager, PV I | Novo Nordisk | Taipei, Taiwan | 2026-06-25 |